Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Building better relations with tomorrow’s doctors

May 6, 2009 Sales and Marketing doctors, industry relations

A huge amount of time and money is spent by the pharma industry on interacting with the medical community and …
Feature

Bayer launches UK television ads for its morning-after pill

May 6, 2009 Sales and Marketing Bayer

Bayer Schering Pharma has launched a television advertising campaign for its morning-after pill Levonelle One Step in the UK. The …
News

Ranbaxy woes continue with antibiotic recall

May 6, 2009 Sales and Marketing Ranbaxy, US

Indian drugmaker Ranbaxy Laboratories has recalled an antibiotic on sale in the US, suggesting that it still has some way …
News

Bayer Schering’s contraceptive patch enters phase III

May 5, 2009 Research and Development, Sales and Marketing Bayer, sexual health

Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …
News

Pfizer dips in first quarter

May 1, 2009 Sales and Marketing Pfizer

Pfizer saw its performance dip in the first quarter of 2009, with revenue down 8% year-on-year. The company, which is …
News

BMS turns in solid first quarter results

May 1, 2009 Sales and Marketing BMS

Bristol-Myers Squibb turned in respectable figures for the first quarter of 2008, with net income up 5% to $921 million. …
News

UK’s branded pharma sales predicted to decline

May 1, 2009 Sales and Marketing NHS

As part of the UK government's drive to save £2.3 billion in the NHS during 2010-11, £550m will be cut …
News

Developing health, developing profits

April 30, 2009 Research and Development, Sales and Marketing Pfizer, healthcare, working poor

Pfizer's Dr Ponni Subbiah is at the forefront of a revolution in the way the pharma industry views its business, …
Feature

Recession hits Merck KGaA profits

April 29, 2009 Sales and Marketing Merck Serono

Merck KGaA saw its profits fell through the floor for the first quarter this year due to a combination of …
News

IDIS and Ogilvy to promote named patient programme

April 28, 2009 Medical Communications, Sales and Marketing IDIS, Ogilvy

Specialist medicines supplies company IDIS has hired a leading PR agency to help promote its business across Europe. Ogilvy Healthworld …
News

The changing face of Continuing Medical Education in Europe

April 28, 2009 Medical Communications, Sales and Marketing Continuing medical education, Europe

There is currently no unified approach to delivering Continuing Medical Education (CME) in Europe, and the provision of CME is …
Feature

AZ’s Iressa to make comeback

April 28, 2009 Research and Development, Sales and Marketing AZ, Iressa

AstraZeneca's Iressa is set to make a comeback after a European committee recommended its use for a sub-group of lung …
News

GSK and Pfizer joint venture more than a defensive move

April 27, 2009 Research and Development, Sales and Marketing GSK, Pfizer

GSK and Pfizer have agreed to merge their respective HIV businesses, creating a single specialist entity with total pro-forma sales …
News

Strong prospects for Novartis cancer drug, say analysts

April 24, 2009 Research and Development, Sales and Marketing Afinitor, Novartis

The FDA has approved Novartis's Afinitor for advanced renal cell carcinoma patients who have progressed after first-line Sutent or Nexavar …
News

GSK freezes prices in Germany as part of PR trail

April 24, 2009 Sales and Marketing GSK, Germany

GlaxoSmithKline has announced a price freeze on its drugs and vaccines in Germany for 2009. The freeze applies to drugs …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026